The Food and Drug Administration said several lots of six products containing benzoyl peroxide are being recalled, including ...
Parent company La Roche-Posay has pulled the Effaclar Duo Acne Spot Treatment from L'Oreal's lineup, due to a cancer-causing ...
Acne creams from retailers including Walgreens, La Roche-Posay and Proactiv have been voluntarily recalled due to elevated levels of a potentially cancer-causing agent.
The FDA tested 95 products containing benzoyl peroxide, an ingredient widely used to treat acne that can form benzene as a byproduct. It found that six products could have more benzene than usual.
The Real Deal by RetailMeNot on MSN6h
Daily Freebie: La Roche-Posay Mela B3 Dark Spot Serum
Today’s freebie alert is for a luxurious skincare treat! Get a free sample of the Mela B3 Dark Spot Serum from La Roche-Posay. If you’re no beauty maven and not already familiar, this ...
Here, we get into the details about the La Roche-Posay recall, what you should know and alternative acne treatments you should try. La Roche-Posay’s Effaclar Duo was launched in 2014 and has ...
L’Oreal has recalled all U.S. lots of La Roche-Posay’s Effaclar Duo acne treatment due to concerns over benzene contamination, a known carcinogen. Benzoyl peroxide, a key ingredient in ...
The U.S. Food and Drug Administration (FDA) has announced a recall for select acne treatment products after testing revealed elevated levels of benzene, a chemical linked to cancer. The agency […] The ...
L'Oréal has urgently recalled one of its popular La Roche Posay face creams over fears it contains a cancer-causing chemical. The cosmetics giant stuck a 'do not use' alert on its ...
L’Oreal’s Effaclar Duo, sold under the French company’s La Roche-Posay brand, is made with benzoyl peroxide, which kills bacteria to help treat acne. Valisure, an independent lab in ...
Swiss pharmaceutical company Roche announced Friday it will open an innovation center in the Harvard University Enterprise Research Campus in Allston that could employ hundreds. The Roche ...